Correlation between spasticity and quality of life in patients with multiple sclerosis: The CANDLE study

International Journal of Neuroscience

Volumn 123, Issue 12, 2013, Pages 850-858

  Arroyo, Rafael ^a   Massana, Mariona ^b   Vila, Carlos ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Medical Department ^*  (Spain)

Author keywords

Multiple sclerosis; Quality of life; Spain; Spasticity scales

Indexed keywords

BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; GABAPENTIN; TIZANIDINE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SHORT FORM 12; SPASTICITY; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIOECONOMICS; STATISTICS; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84887957067     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.812084     Document Type: Article

References (13)

1. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004;10:589-95.
2. Barnes MP, Kent RM, Semlyen JK, McMullen KM. Spasticity in multiple sclerosis. Neurorehab Neural Re 2003;17(1):66-70.
3. Arroyo R, Vila C, Clissold S. Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the '5E' study. Expert Rev Pharmacoecon Outcomes Res 2011;11(2):205-13.
4. Rekand T. Clinical assessment and management of spasticity: a review. Acta Neurol Scand Suppl 2010;(190):62-6.
5. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67(2):206-7.
6. Haugh AB, Pandyan AD, Johnson GR. A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil 2006;28(15):899-907.
7. Farrar JT, Troxel AB, Stott C, et al. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther 2008;30(5): 974-85.
8. Zwibel HL, Smrtka J. Improving quality of life in multiple sclerosis: an unmet need. Am J Manag Care 2011;17(Suppl 5):S139-45.
9. Mitchell AJ, Benito-Léon J, González JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005;4(9):556-66.
10. Farrar JT, Troxel AB, Stott C, et al. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, doubleblind, placebo-controlled trial. Clin Ther 2008;30(5):974-85.
11. Anwar K, Barnes MP. A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis. Neurorehabilitation 2009;24:333-40.
12. Ares B, Prieto JM, Lema M, et al. Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain). Mult Scler 2007;13(2):262-4.
13. Oreja-Guevara C, González-Segura D, Vila C. Spasticity in multiple sclerosis: results of a patient survey. Int J Neurosci. 2013 Jun;123(6):400-8.